Showing results (511-520 of 607) with videos related to
Sort By:
Pageof 61
Leukemia|November 24, 2023
Prognostic implications of CD9 in childhood acute lymphoblastic leukemia: insights from a nationwide multicenter study in ChinaKam Tong Leung, Jiaoyang Cai, Yu Liu, et al.JAMA Oncology|August 19, 2021
Association of Combined Focal 22q11.22 Deletion and IKZF1 Alterations With Outcomes in Childhood Acute Lymphoblastic LeukemiaDavid Spencer Mangum, Julia A Meyer, Clinton C Mason, et al.The New England Journal of Medicine|June 26, 2009
Treating childhood acute lymphoblastic leukemia without cranial irradiationChing-Hon Pui, Dario Campana, Deqing Pei, et al.Journal of the National Cancer Institute|January 17, 2024
Additive effects of TPMT and NUDT15 on thiopurine toxicity in children with acute lymphoblastic leukemia across multiethnic populationsMaud Maillard, Rina Nishii, Wenjian Yang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2012
ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemiaHeng Xu, Cheng Cheng, Meenakshi Devidas, et al.Nature Genetics|February 8, 2011
Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemiaJun J Yang, Cheng Cheng, Meenakshi Devidas, et al.JAMA|January 30, 2009
Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemiaJun J Yang, Cheng Cheng, Wenjian Yang, et al.British Journal of Haematology|September 16, 2022
Extended vincristine and dexamethasone pulse therapy may not be necessary for children with TCF3-PBX1 positive acute lymphoblastic leukaemiaYang Wan, Honghong Zhang, Li Zhang, et al.Pediatric Blood & Cancer|March 9, 2019
No evidence that G6PD deficiency affects the efficacy or safety of daunorubicin in acute lymphoblastic leukemia induction therapyKatherine M Robinson, Wenjian Yang, Seth E Karol, et al.Blood|January 9, 2025
Prognostic and therapeutic implications of measurable residual disease levels during remission induction of childhood ALLWeina Zhang, Jiaoyang Cai, Xiang Wang, et al.Pageof 61